These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20934178)

  • 21. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.
    Farid AS; Horii Y
    Lipids Health Dis; 2012 Jul; 11():92. PubMed ID: 22824324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase genes and disease.
    Hegele RA
    Ann Med; 1999 Jun; 31(3):217-24. PubMed ID: 10442677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment.
    Marsillach J; Aragonès G; Beltrán R; Caballeria J; Pedro-Botet J; Morcillo-Suárez C; Navarro A; Joven J; Camps J
    Clin Biochem; 2009 Jan; 42(1-2):91-8. PubMed ID: 18977341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
    Ng CJ; Wadleigh DJ; Gangopadhyay A; Hama S; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    J Biol Chem; 2001 Nov; 276(48):44444-9. PubMed ID: 11579088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.
    Aviram M; Rosenblat M
    Free Radic Biol Med; 2004 Nov; 37(9):1304-16. PubMed ID: 15454271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of paraoxonases: a brief review.
    Draganov DI; La Du BN
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection.
    Khalil A; Fulop T; Berrougui H
    Antioxid Redox Signal; 2021 Jan; 34(3):191-200. PubMed ID: 31969002
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
    Ferretti G; Bacchetti T
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
    Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
    Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.
    She ZG; Chen HZ; Yan Y; Li H; Liu DP
    Antioxid Redox Signal; 2012 Mar; 16(6):597-632. PubMed ID: 21867409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
    Ng CJ; Bourquard N; Grijalva V; Hama S; Shih DM; Navab M; Fogelman AM; Lusis AJ; Young S; Reddy ST
    J Biol Chem; 2006 Oct; 281(40):29491-500. PubMed ID: 16891303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of paraoxonase in cancer.
    Bacchetti T; Ferretti G; Sahebkar A
    Semin Cancer Biol; 2019 Jun; 56():72-86. PubMed ID: 29170064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.
    Cao H; Girard-Globa A; Berthezene F; Moulin P
    J Lipid Res; 1999 Jan; 40(1):133-9. PubMed ID: 9869659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase activity as a marker of exposure to xenobiotics in tobacco smoke.
    Milnerowicz H; Kowalska K; Socha E
    Int J Toxicol; 2015; 34(3):224-32. PubMed ID: 25953737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.